LUXBreast1_4: LUXBreast1, figure 4

LUXBreast1_4R Documentation

LUXBreast1, figure 4

Description

Kaplan-Meier digitized data from LUXBreast1, figure 4 (PMID 26822398). A reported sample size of 508 for a primary endpoint of PFS in breast cancer.

Usage

LUXBreast1_4

Format

A data frame of 508 observations and 3 variables:

time event time (in months)
event OS event indicator (0: no event, 1: event)
arm treatment arms (afatinib, t)

Source

Harbeck N, Huang C-S, Hurvitz S, et al. Afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one previous trastuzumab treatment (LUX-Breast 1): an open-label, randomised, phase 3 trial. Lancet Oncol 2016; 17: 357–66.

Examples

summary(LUXBreast1_4)

kmplot(LUXBreast1_4)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.